(Q41655232)

6 October 2017

Binding to CD4 of synthetic peptides patterned on the principal neutralizing domain of the HIV-1 envelope protein (English)

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90553-N

8 November 2022

author name string

M. Autiero

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1720590

8 November 2022

P. Abrescia

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1720590

8 November 2022

M. Dettin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1720590

8 November 2022

C. Di Bello

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1720590

8 November 2022

J. Guardiola

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1720590

8 November 2022

language of work or name

English

0 references

publication date

1 December 1991

1 reference

full work available at URL

6 October 2017

https://api.elsevier.com/content/article/PII:004268229190553N?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90553-N

https://api.elsevier.com/content/article/PII:004268229190553N?httpAccept=text/plain

8 November 2022

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90553-N

8 November 2022

1 reference

6 October 2017

185

1 reference

6 October 2017

820-828

1 reference

6 October 2017

2

1 reference

Identification of the residues in human CD4 critical for the binding of HIV.

6 October 2017

1

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90553-N

A soluble recombinant polypeptide comprising the amino-terminal half of the extracellular region of the CD4 molecule contains an active binding site for human immunodeficiency virus

8 November 2022

2

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90553-N

A CD4 domain important for HIV-mediated syncytium formation lies outside the virus binding site

8 November 2022

4

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90553-N

Designing CD4 immunoadhesins for AIDS therapy

8 November 2022

5

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90553-N

Involvement of the CD4 molecule in a post-activation event on T cell proliferation

8 November 2022

6

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90553-N

Stimulation and proliferation of CD4+ peripheral blood T lymphocytes induced by an anti-CD4 monoclonal antibody

8 November 2022

7

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90553-N

Antibody raised against soluble CD4-rgp120 complex recognizes the CD4 moiety and blocks membrane fusion without inhibiting CD4-gp120 binding

8 November 2022

8

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90553-N

Identification of human CD4 residues affecting class II MHC versus HIV-1 gp120 binding

8 November 2022

9

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90553-N

Single amino-acid changes in HIV envelope affect viral tropism and receptor binding

8 November 2022

10

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90553-N

A soluble form of CD4 (T4) protein inhibits AIDS virus infection

8 November 2022

11

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90553-N

Synthetic peptides from the principal neutralizing domain of human immunodeficiency virus type 1 (HIV-1) enhance HIV-1 infection through a CD4-dependent mechanism

8 November 2022

12

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90553-N

Epitope mapping of the human immunodeficiency virus type 1 gp120 with monoclonal antibodies

8 November 2022

13

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90553-N

HIV infection is blocked in vitro by recombinant soluble CD4.

8 November 2022

14

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90553-N

AIDS pathogenesis: HIV envelope and its interaction with cell proteins

8 November 2022

15

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90553-N

Novel anti-CD4 monoclonal antibodies separate human immunodeficiency virus infection and fusion of CD4+ cells from virus binding

8 November 2022

16

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90553-N

A soluble CD4 protein selectively inhibits HIV replication and syncytium formation

8 November 2022

18

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90553-N

Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1.

8 November 2022

19

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90553-N

Location and chemical synthesis of a binding site for HIV-1 on the CD4 protein.

8 November 2022

20

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90553-N

Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein

8 November 2022

21

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90553-N

Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant

8 November 2022

23

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90553-N

Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor

8 November 2022

24

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90553-N

HIV requires multiple gp120 molecules for CD4-mediated infection

8 November 2022

25

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90553-N

Synthetic CD4 peptide derivatives that inhibit HIV infection and cytopathicity

8 November 2022

26

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90553-N

Binding region for human immunodeficiency virus (HIV) and epitopes for HIV-blocking monoclonal antibodies of the CD4 molecule defined by site-directed mutagenesis

8 November 2022

27

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90553-N

Simple methods for monitoring HIV-1 and HIV-2 gp120 binding to soluble CD4 by enzyme-linked immunosorbent assay: HIV-2 has a 25-fold lower affinity than HIV-1 for soluble CD4

8 November 2022

28

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90553-N

HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain

8 November 2022

30

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90553-N

Complete nucleotide sequence of the AIDS virus, HTLV-III

8 November 2022

32

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90553-N

Structural analysis of the human immunodeficiency virus-binding domain of CD4. Epitope mapping with site-directed mutants and anti-idiotypes

8 November 2022

34

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90553-N

The CD4 antigen: physiological ligand and HIV receptor

8 November 2022

35

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90553-N

Epitopes of the CD4 antigen and HIV infection

8 November 2022

36

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90553-N

HIV envelope-CD4 interaction not inhibited by synthetic octapeptides

8 November 2022

38

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90553-N

Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS.

8 November 2022

39

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90553-N

Soluble CD4 molecules neutralize human immunodeficiency virus type 1.

8 November 2022

40

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90553-N

8 November 2022

Identifiers

1 reference

6 October 2017

1 reference